IL-15 enhanced CD158a expression in SLE patient (6.5±0.8% vs. 4.3±0.7%, p<0.001) as well as controls (11.3±1.7% vs. 4.0±0.8%, p = 0.012). This evidence concerns the gene KIR2DL1 and systemic lupus erythematosus.